Search Results - Byrne, Jenny
- Showing 1 - 3 results of 3
-
1
A phase 2 trial of decreasing tyrosine kinase inhibitor dose in chronic myeloid leukaemia patients with stable major molecular response: data from the British DESTINY study by Clark, Richard E., Polydoros, Fotios, Apperley, Jane F., Milojkovic, Dragana, Pocock, Christopher, Smith, Graeme, Byrne, Jenny L., de Lavallade, Hugues, O'Brien, Stephen G., Coffey, Tony, Foroni, Letizia, Copland, Mhairi
Published 2017Get full text
-
2
Allogeneic stem cell transplantation in patients with atypical chronic myeloid leukaemia: a retrospective study from the Chronic Malignancies Working Party of the European Societ... by Onida, Francesco, De Wreede, Lliesbeth C., van Blezan, Anja, Elkema, Diderik-Jan, Byrne, Jenny L., Iori, Anna P., Schots, Rick, Jungova, Alexandra, Schetelig, Johannes, Finke, Juergen, Veelken, Hendrick, Johanssen, Jan-Erik, Craddock, Charles, Stellies, Matthias, Theobald, Matthias, Holler, Ernst, Schanz, Urs, Schaap, Nicolaas, Bittenbring, Joerg, Olivaria, Eduardo, Chalandan, Yves, Kroger, Nicolaus
Published 2017Get full text
-
3
High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignanc... by Cook, Gordon, Iacobelli, Simona, van Biezen, Anja, Ziegkos, Dimitris, La Blond, Veronique, Abraham, Julie, McQuaker, Grant, Schoenland, Stefan, Rambaldi, Alessandro, Halaburda, Kazimierz, Rovira, Maria, Sica, Simona, Byrne, Jenny, Garcia Sanz, Ramon, Nagler, Aarnon, van der Donk, Niels W.C.J., Sinisalo, Marjatta, Cook, Mmark, Kroger, Nicolaus, de Witte, Theo, Morris, Curly, Garderet, Laurent
Published 2017Get full text